W
WAVEMAN · COMPANY
NATR · Natures Sunshine Products Inc
> Ask across nine datasets ⌘K
LIVE
TEAM-0.32% 13F +439META+3.01% 13F +2,694RCG-2.04% CLUSTERUTHR-4.03% 13F +425CRWV+4.49% 13F +693CRM+2.92% 13F +1,018CVNA-0.98% 13F +794TPL-0.71% 13F +444NET+4.32% 13F +710MSTR+17.56% 13F +526DELL+4.91% 13F +1,203CRWD+5.68% 13F +1,382ANET+1.22% 13F +1,323COIN+10.14% 13F +475TEAM-0.32% 13F +439META+3.01% 13F +2,694RCG-2.04% CLUSTERUTHR-4.03% 13F +425CRWV+4.49% 13F +693CRM+2.92% 13F +1,018CVNA-0.98% 13F +794TPL-0.71% 13F +444NET+4.32% 13F +710MSTR+17.56% 13F +526DELL+4.91% 13F +1,203CRWD+5.68% 13F +1,382ANET+1.22% 13F +1,323COIN+10.14% 13F +475
← ALL COMPANIES

NATR

NATURES SUNSHINE PRODUCTS INC
PHARMA & BIOTECH · PHARMACEUTICAL PREPARATIONS · CIK 0000275053
SEC FILINGS☆ WATCH
INSIDER NET · 180D
$919.1K
open-market buys minus sells, Form 4 codes P and S
INSIDER BUYERS · 180D
1
CONGRESS BUYERS · 1Y
0
FUNDS ADDED · QTR
69
13F, latest reported quarter
REVENUE GROWTH
+5.7%
XBRL, annual
NET MARGIN
4.1%
CONVERSIONS · 180D
18
codes C/M, not in net · $0 priced
SEVEN FACTS, RANKED AGAINST THE SECTOR · RANK IS NOT A FORECAST
INSIDERS
net +$919.1K over 180 days
+$2.6M over 90 days · +$2.6M of it by a 10%+ holder
more than 88% of Pharma & Biotech
CONGRESS
no member of Congress has reported trading it
FUNDS
69 funds added or opened last quarter
more than 53% of Pharma & Biotech
REVENUE
+5.7% year over year
more than 55% of Pharma & Biotech
MARGIN
4.1% net margin
more than 73% of Pharma & Biotech
BUYBACKS
$2.6M repurchased, FY to 2026-06-30
below 81% of Pharma & Biotech
SHORT
2.9% of shares outstanding short · 5.1 days to cover · settled 2026-07-31
below 58% of Pharma & Biotech
THE SITUATION · EVERY LINE IS ONE RULE OVER ONE DATASET
69 funds added or opened positions in the latest 13F quarter, of 155 holders.
The year, with the filings on it
Total return indexed to 100 over the last 12 months · every marker is a federal filing, placed at its date — hover any marker for the detail
TOTAL 12M RETURN -17.9%
-17.9%12M
-22%+7%+36%+65%2025-092025-102025-122026-032026-052026-072026-09 2026-08-07 · PRESCOTT GROUP CAPITAL MANAGEMENT, L.L.C. bought $500.4K2026-03-13 · Yates Bryant J sold $475.2K2026-03-13 · Norman Daniel C sold $377.2K2026-08-07 · PRESCOTT GROUP CAPITAL MANAGEMENT, L.L.C. bought $333.8K2026-08-07 · PRESCOTT GROUP CAPITAL MANAGEMENT, L.L.C. bought $331.0K2026-08-17 · PRESCOTT GROUP CAPITAL MANAGEMENT, L.L.C. bought $293.8K2026-08-10 · PRESCOTT GROUP CAPITAL MANAGEMENT, L.L.C. bought $267.5K2026-05-21 · Brower Nathan G sold $262.4K2026-06-05 · Yates Bryant J sold $238.2K2026-08-10 · PRESCOTT GROUP CAPITAL MANAGEMENT, L.L.C. bought $206.3K2026-06-01 · Norman Daniel C sold $200.5K2025-11-12 · Norman Daniel C sold $181.8K2026-08-07 · PRESCOTT GROUP CAPITAL MANAGEMENT, L.L.C. bought $167.2K2026-08-07 · PRESCOTT GROUP CAPITAL MANAGEMENT, L.L.C. bought $164.6K2026-08-10 · PRESCOTT GROUP CAPITAL MANAGEMENT, L.L.C. bought $160.1K2025-11-18 · Lanoy Jonathan David sold $102.2K2026-03-13 · Lanoy Jonathan David sold $98.8K2026-08-07 · PRESCOTT GROUP CAPITAL MANAGEMENT, L.L.C. bought $83.1K2025-11-14 · Brower Nathan G sold $79.1K2026-08-06 · PRESCOTT GROUP CAPITAL MANAGEMENT, L.L.C. bought $42.1K2025-12-12 · Yates Bryant J sold $37.9K2026-08-06 · PRESCOTT GROUP CAPITAL MANAGEMENT, L.L.C. bought $32.7K2026-06-12 · Herbert Kevin R. sold $23.4K2026-06-12 · Herbert Kevin R. sold $18.0K2026-08-07 · PRESCOTT GROUP CAPITAL MANAGEMENT, L.L.C. bought $16.5K2026-08-10 · PRESCOTT GROUP CAPITAL MANAGEMENT, L.L.C. bought $13.7K
INSIDER BUYINSIDER SELL
INDEXED RETURN, DIVIDEND-ADJUSTED — NOT A PRICE CHART · LARGE TRADES DRAWN FIRST WHEN A NAME FILES HEAVILY
Live price
Daily candles from TradingView, on their licence — no filings are marked on this one
WHY THIS NAME IS ON THE DESK
Insiders are net buyers of their own stock.
The record shows a net $919.1K bought by insiders over 180 days, 69 funds added last quarter. Every figure is a federal filing, dated the day it became public.
Backtest this pattern Open the screener
Same sector, ranked by filing activity
Sector from the SEC's own SIC classification
UTHRCPIXMRNAREGNLLYALNYELFCITRMDGLDNAVRTXNUVL
Insider transactions
Form 4 purchases and sales (codes P and S) — grants, option exercises and preferred conversions excluded

Over the last 180 days, NATURES SUNSHINE PRODUCTS INC insiders bought a net $919.1K of stock across 81 Form 4 purchases and sales, with 1 insider(s) buying. Source: SEC Form 4 filings, as of 2026-09-05.

INSIDER
FILED
SHARES
VALUE
PRESCOTT GROUP CAPITAL MANAGEMENT, L.L.C.
—
BUY
2026-08-17
20,000.0
$293.8K
PRESCOTT GROUP CAPITAL MANAGEMENT, L.L.C.
—
BUY
2026-08-10
876.0
$13.7K
PRESCOTT GROUP CAPITAL MANAGEMENT, L.L.C.
—
BUY
2026-08-10
16,928.0
$267.5K
PRESCOTT GROUP CAPITAL MANAGEMENT, L.L.C.
—
BUY
2026-08-10
13,072.0
$206.3K
PRESCOTT GROUP CAPITAL MANAGEMENT, L.L.C.
—
BUY
2026-08-10
10,000.0
$160.1K
81 TRANSACTIONS ON RECORD

Showing the most recent few. Create a free account to see 76 more transactions on record, the cross-source screener and CSV export. We store only your email address, and there is no password to create.

Institutional holders
13F · holdings as of the latest quarter funds have reported
WYNNEFIELD CAPITAL INC
2,473,686.0 sh
$53.9M
Prescott Group Capital Management, L.L.C.
1,783,097.0 sh
$38.9M
BlackRock, Inc.
989,020.0 sh
$21.6M
DIMENSIONAL FUND ADVISORS LP
923,626.0 sh
$20.1M
AMERICAN CENTURY COMPANIES INC
714,829.0 sh
$15.6M
SCHEDULE 13D/G
No 5%+ ownership filings
Nobody has crossed 5% with a filing obligation. Absence is a fact here, not missing data.
FORM 144
No planned-sale notices
No insider has notified an intent to sell. This is the panel to watch after a run-up.
Fund concentration
N-PORT · funds ranked by how much of THEMSELVES they put in this stock — the conviction number 13F cannot show
NORTH SQUARE KENNEDY MICROCAP FUND
$578.8K POSITION · AS OF 2026-02-28
1.9%
North Star Micro Cap Fund
$2.7M POSITION · AS OF 2026-02-28
1.5%
Boston Partners Small Cap Value Fund II
$4.4M POSITION · AS OF 2026-02-28
0.6%
First Trust Dow Jones Select MicroCap Index Fund
$1.1M POSITION · AS OF 2026-03-31
0.5%
Ultra-Small Company Fund
$383.8K POSITION · AS OF 2026-03-31
0.4%
Franklin Small Cap Enhanced ETF
$500.3K POSITION · AS OF 2026-03-31
0.4%
SEC N-PORT, MONTHLY WITH A ~60-DAY PUBLIC LAG · FUNDS ≥ $10M · % = SHARE OF THE FUND'S OWN BOOK
Executive pay vs shareholder return · Terrence Moorehead
DEF 14A pay-versus-performance disclosure · both the headline pay and the SEC's mark-to-market figure, beside the return the company delivered and the return of the peer group it chose itself
FY
CEO TOTAL
ACTUALLY PAID
OTHER NEOs AVG
TSR
PEER TSR
2022
$2.8M
$94.4K
$1.1M
-2%
—
TAGGED BY THE COMPANY UNDER SEC ITEM 402(v) · RETURN IS CUMULATIVE FROM THE START OF THE DISCLOSURE PERIOD · GREEN WHERE THE COMPANY BEAT ITS OWN PEER GROUP
Fundamentals
Annual figures from XBRL filings · pick a past date to see them exactly as the market knew them then — restatements and all
2025-122024-122023-122022-12
REVENUE$480.1M$454.4M$445.3M$421.9M
GROSS PROFIT$347.7M$324.7M$321.1M$299.8M
OPERATING INCOME$24.7M$20.1M$18.7M$16.3M
NET INCOME$19.5M$7.7M$15.1M$-390.0K
EPS (DILUTED)1.060.400.77-0.02
OPERATING CASH FLOW$35.3M$25.3M$41.2M$710.0K
CASH$93.9M$84.7M$82.4M$60.0M
LONG-TERM DEBT———$0
BUYBACKS$16.3M$8.9M$6.4M$13.6M
DIVIDENDS PAID———$0
SEC XBRL · FISCAL-YEAR PERIODS · AS KNOWN ON 2026-09-05 · NOBODY ELSE SHOWS FUNDAMENTALS AS OF A PAST DATE
W WAVEMAN

Public filings, honestly analyzed. Official US government sources in one desk — every figure carries the date it was filed, and the methodology is published, backtest included.

SEC FORM 4FORM 13F 13D/GFORM 144XBRL STOCK ACTCONTRACTSFEC CFPBNRC
PRODUCT
DeskBacktester CompaniesAccount
SUPPORT
FAQMethodology Contact
LEGAL
TermsPrivacy Accessibility
© 2026 WAVEMAN · SOURCE: SEC EDGAR & OFFICIAL GOVERNMENT DATA · NOT INVESTMENT ADVICE · CHART BY TRADINGVIEW · UPDATED 2026-09-05 ALL SYSTEMS LIVE FOR MACHINES →